Core Laboratories NV

Company Profile

Core Laboratories NV had its IPO on 1995-09-20 under the ticker symbol CLB.

The company operates in the Energy sector and Oil & Gas Equipment & Services industry. Core Laboratories NV has a staff strength of 3,600 employees.

Stock update

Shares of Core Laboratories NV opened at $25.94 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $25.2 - $26.47, and closed at $25.58.

This is a +0.24% increase from the previous day's closing price.

A total volume of 409,197 shares were traded at the close of the day’s session.

In the last one week, shares of Core Laboratories NV have increased by +2.65%.

Core Laboratories NV's Key Ratios

Core Laboratories NV has a market cap of $1.11 billion, indicating a price to book ratio of 5.057 and a price to sales ratio of 1.7985.

In the last 12-months Core Laboratories NV’s revenue was $502.79 million with a gross profit of $96.08 million and an EBITDA of $65.45 million. The EBITDA ratio measures Core Laboratories NV's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Core Laboratories NV’s operating margin was 9.7% while its return on assets stood at 5.18% with a return of equity of 13.06%.

In Q1, Core Laboratories NV’s quarterly earnings growth was a positive 151.7% while revenue growth was a positive 11.3%.

Core Laboratories NV’s PE and PEG Ratio

Forward PE

19.084

Trailing PE

46.451

PEG

0.493

Its diluted EPS in the last 12-months stands at $0.51 per share while it has a forward price to earnings multiple of 19.084 and a PEG multiple of 0.493. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Core Laboratories NV’s profitability.

Core Laboratories NV stock is trading at a EV to sales ratio of 2.3091 and a EV to EBITDA ratio of 19.5382. Its price to sales ratio in the trailing 12-months stood at 1.7985.

Core Laboratories NV stock pays annual dividends of $0.04 per share, indicating a yield of 0.17% and a payout ratio of 5.8%.

Balance sheet and cash flow metrics

Total Assets

$593.62 million

Total Liabilities

$95.62 million

Operating Cash Flow

$-2038000.00

Capital Expenditure

$2.21 million

Dividend Payout Ratio

5.8%

Core Laboratories NV ended 2024 with $593.62 million in total assets and $0 in total liabilities. Its intangible assets were valued at $593.62 million while shareholder equity stood at $200.15 million.

Core Laboratories NV ended 2024 with $52.04 million in deferred long-term liabilities, $95.62 million in other current liabilities, 1194000.00 in common stock, $2.84 million in retained earnings and $99.45 million in goodwill. Its cash balance stood at $16.29 million and cash and short-term investments were $16.29 million. The company’s total short-term debt was $11,073,000 while long-term debt stood at $180.44 million.

Core Laboratories NV’s total current assets stands at $227.93 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $110.70 million compared to accounts payable of $38.37 million and inventory worth $67.34 million.

In 2024, Core Laboratories NV's operating cash flow was $-2038000.00 while its capital expenditure stood at $2.21 million.

Comparatively, Core Laboratories NV paid $0.06 in dividends in 2024.

Other key metrics

Current Trading Price

$25.58

52-Week High

$31.3583

52-Week Low

$13.1722

Analyst Target Price

$22.81

Core Laboratories NV stock is currently trading at $25.58 per share. It touched a 52-week high of $31.3583 and a 52-week low of $31.3583. Analysts tracking the stock have a 12-month average target price of $22.81.

Its 50-day moving average was $24.62 and 200-day moving average was $22.98 The short ratio stood at 11.29 indicating a short percent outstanding of 0%.

Around 66.1% of the company’s stock are held by insiders while 10635% are held by institutions.